Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab Effect on Esophageal Peristalsis in EoE
NCT06665971Phase 4Recruiting
- Sponsor
- University of California, San Diego
- Start
- Nov 2024
- Primary completion
- Sep 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab in eosinophilic esophagitis (EoE), sponsored by University of California, San Diego. Started Nov 2024; status: recruiting.
02
Drugs
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT06665971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06665971.